Stocktoria
Mereo BioPharma Group plc MREO
Mereo BioPharma Group plc statistics & valuation
Market cap$47.3M
P / S94.7×
P / B1.2×
Net margin-8375.6%
Return on equity-102.4%
FCF margin-6198.2%
Return on capital-96.4%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Operating margin | -8021.4% | — | -284.2% | — |
| Net margin | -8375.6% | — | -294.7% | — |
| FCF margin | -6198.2% | — | -211.3% | — |
| Return on assets | -91.2% | -56.6% | -44.3% | -54.5% |
| Return on equity | -102.4% | -70.9% | -58.3% | -82.1% |
| Current ratio | 10.46 | 5.40 | 6.72 | 3.09 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.